Reconstruction of supracrestal alveolar bone lost as a result of severe chronic periodontitis. Five-year outcome: Case report

International Journal of Periodontics and Restorative Dentistry

Volumn 26, Issue 5, 2006, Pages 425-431

  Kotschy, Peter ^a   Laky, Markus ^b  

^a Vienna Medical University ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIO OSS; BIO-OSS; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; MINERAL;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BONE MATRIX; BONE PROSTHESIS; BONE REGENERATION; BONE TRANSPLANTATION; CASE REPORT; CATTLE; CHRONIC DISEASE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; METHODOLOGY; MIDDLE AGED; OSTEOLYSIS; PERIODONTICS; PERIODONTITIS; PLASTIC SURGERY; TRANSPLANTATION; TREATMENT OUTCOME;

ALVEOLAR BONE LOSS; ANIMALS; BONE MATRIX; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; CATTLE; CHRONIC DISEASE; DENTAL ENAMEL PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MINERALS; PERIODONTAL INDEX; PERIODONTITIS; SURGICAL FLAPS; TREATMENT OUTCOME;

EID: 33749490493     PISSN: 01987569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-677.
2. Gestrelius S, Andersson C, Lidström D, Hammarström L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivatives. J Clinical Periodontol 1997;24:685-692.
3. Zetterström O, Andersson C, Eriksson A, et al. Clinical safety of enamel matrix derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol 1997;24:697-704.
4. Heijl L, Heden G, Svärdström G, Östgren A. Enamel matrix derivative in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
5. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997;24:693-696.
6. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:9-19.
7. Trombelli L, Bottega S, Zucchelli G. Supracrestal soft issue preservation with enamel matrix proteins in treatment of deep intrabony defects. A report of 35 consecutively treated cases. J Clin Periodontol 2002;29:433-439.
8. Zucchelli G, Brenardi F, Montebugnoli L, De Sanctis M. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: A comparative controlled clinical trial. J Periodontol 2002;73:3-12.
9. Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996;1: 621-666.
10. Valentini P, Abensur D. Maxillary sinus floor elevation for implant placement with demineralized freeze-dried bone and bovine bone (Bio-Oss): A clinical study of 20 patients. Int J Periodontics Restorative Dent 1997;17:233-241.
11. Halman M, Lundgren S, Sennerby L. Histologic analysis of clinical biopsies taken 6 months and 3 years after maxillary sinus floor augmentation with 80% bovine hydroxyapatite and 20% autogenous bone mixed with fibrin glue. Clin Implant Dent Relat Res 2001;3:87-96.
12. Berglundh T, Lindhe J. Healing around implants placed in bone defects treated with Bio-Oss. An experimental study in the dog. Clin Oral Implants Res 1997;8: 117-124.
13. Hutchens LH Jr. The use of a bovine bone mineral in periodontal osseous defects: Case reports. Compend Cont Educ Dent 1999;20:365-378.
14. Camelo M, Nevins ML, Schenk RK. Clinical radiographic and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide. Int J Periodontics Restorative Dent 1998;18:321-331.
15. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of infrabony periodontal defects in humans. J Periodontol 2000;71:1110-1116.
16. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT. A clinical comparison of a bovine derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:423-432.
17. Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73: 433-440.
18. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenney EB, Madzarevic M. The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans. J Clin Periodontol 2001;28:1016-1022.
19. Rooney J, Wade WG, Sprague SV, Newcombe RG, Addy M. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. Placebo controlled study. J Clin Periodontol 2002;29: 342-350.
20. Cortellini P, Pini Prato G, Tonetti MS. The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 1995;66:261-266.
21. Cortellini P, Pini Prato G, Tonetti MS. The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 1999;19: 589-599.
22. Kotschy P, Muenzker R. New dimensions in guided tissue regeneration treatment modalities for profound marginal periodontitis. Int J Periodontics Restorative Dent 1995;15:285-297.